Figure 9. Potential role of risk signature in immune checkpoints. (A) Expression of immune checkpoints among two risk subgroups in UCEC patients. (B) Expression levels of genes PD-L1 in risk subgroups. (C) Correlation analysis between risk score and PD-L1.